Mandate

Vinge advises Fractal Gaming Group AB (publ) in connection with its listing on Nasdaq First North Premier Growth Market

Vinge advises Fractal Gaming Group AB (publ) (“Fractal”) in connection with its listing on Nasdaq First North Premier Growth Market.

The offering circular was published on 2 February 2021 and first day of trading on Nasdaq First North Premier was 11 February 2021. The offer price was set at SEK 41, corresponding to a total value of the total amount of outstanding shares in the company of approximately SEK 1,194 million. The Offering comprised of 13,418,108 existing shares, corresponding to a total value of approximately SEK 550 million provided an overallotment option was exercised in its entirety.

Fractal is a leading company in the premium segment of PC gaming products. The group was founded in 2010 and its products are currently sold in more than 50 markets worldwide. Fractal is a market leader in premium PC cases in several geographic markets, for example in the Nordic region, is top two in Japan, and holds a top-three position globally. The company also has a strong market position within power supply units, cooling products and fans for gaming computers.

Vinge’s team mainly consisted of Johan Winnerblad, Jesper Schönbeck, Rikard Lindahl, Filip Öhrner, William Kåge, Hannah Kajlinger, Anders Sundin Lundberg, Clara Sohlberg and Olivia Belding.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024